March 4, 2013
Medicines Patent Pool Gets ViiV Voluntary License for Children
ViiV Healthcare has granted a voluntary license to the Medicines Patent Pool (MPP) for pediatric formulations of the antiretroviral drug abacavir in 118 countries, according to a ViiV statement. The World Health Organization (WHO) currently recommends abacavir as a preferred nucleoside reverse transcriptase inhibitor (NRTI) for first-line therapy in infants and children. Founded in 2010, MPP is a United Nations–backed group that aims to lower HIV drug prices.
To read the statement, click here.
Search: Medicines Patent Pool, MPP, ViiV, voluntary license, abacavir
Scroll down to comment on this story.
[Go to top]